Original BioMedicals Has Received a Notification of Approval for the Canadian Patent Titled "Composition for Upper Respiratory Tract Drug Delivery and Its Administration Method."
Important News
Our company has received notification from the patent firm that the Canadian Patent Certificate for “Composition for Upper Respiratory Tract Drug Delivery and Its Administration Method” has been granted, under Application No. 3,179,962.
Prev
Original BioMedicals Has Received Patent Approval from the Intellectual Property Office, Ministry of Economic Affairs (Taiwan), for ‘Chelated Composite Micelles with Antibacterial Activity Against Gram-Negative Bacteria and Their Applications.
Original BioMedicals Has Obtained a Chinese Invention Patent for the "Composition and Method for Upper Respiratory Tract Drug Delivery."
